Details of Drug

Details of Drug

 Drug General Information (ID: D0573)
  Drug Name
Enoxacin
  Drug Type Small molecule
  Drug Synonymous
Almitil; Bactidan; Comprecin; Enoram; Enoxacine; Enoxacino; Enoxacinum; Enoxin; Enoxor; Flumark; Penetrex; Enoxacin Sesquihydrate; Enoxacine [French]; Enoxacino [Spanish]; Enoxacinum [Latin]; Faulding Brand of Enoxacin; Pierre Fabre Brand of Enoxacin Sesquihydrate; Rhone Poulenc Rorer Brand of Enoxacin Sesquihydrate; AT 2266; AT2266; CI919; CL23362; E0762; PD 107779; PD107779; AT-2266; Almitil (TN); Bactidan (TN); Bactidron (TN); Comprecin (TN); Enoksetin (TN); Enoxen (TN); Enoxin (TN); Enoxor (TN); Enroxil (TN); Flumark (TN); Gyramid (TN); PD-107779; Penetrex (TN); Rhone-Poulenc Rorer Brand of Enoxacin Sesquihydrate; Sesquihydrate, Enoxacin; Vinone (TN); Enoxacin (USAN/INN); Enoxacin [USAN:BAN:INN:JAN]; 1,8-Naphthyridine-3-carboxylic acid, 6-fluoro-1,4-dihydro-4-oxo-7-piperazinyl; 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid; 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-[1-piperazinyl]-1,8-naphthyridine-3-carboxylic acid; 1-Ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid; 1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid; 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid; 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,8-naphthyridine-3-carboxylic acid
    Click to Show/Hide
  Disease Class GC08: Urinary tract infection
  Therapeutic Class Antiinfective Agents
  Structure Could Not Find 2D Structure
3D Structure 2D Structure
  Formula C15H17FN4O3
  InChI 1S/C15H17FN4O3/c1-2-19-8-10(15(22)23)12(21)9-7-11(16)14(18-13(9)19)20-5-3-17-4-6-20/h7-8,17H,2-6H2,1H3,(H,22,23)
  InChIKey IDYZIJYBMGIQMJ-UHFFFAOYSA-N
  Canonical SMILES CCN1C=C(C(=O)C2=CC(=C(N=C21)N3CCNCC3)F)C(=O)O
  External Link
Pubchem ID 3229
CAS Number 74011-58-8
CHEBI ID 157175
TTD ID D0R8ER
VARIDT ID DR01280

Drug-Drug Interaction Network
  Sunburst Graph
AM001  Affected gastrointestinal absorption
AM003  Affected organization distribution
AM004  Affected intra/extra-hepatic metabolism
AM005  Affected excretion pathways
AM006  Pharmacodynamic additive effects
AM007  Pharmacodynamic antagonistic effects
BM002  Altered intestinal flora
BM003  Complex formation
BM005  Altered gastric pH
BM006  Altered intestinal mucosa
BM014  Interference of cell/tissue uptake
BM017  CYP450 enzyme inhibition
BM028  Competitive inhibition of renal tubular secretion
BM029  Altered urine pH
BM038  Additive CNS depression effects
BM039  Additive CNS stimulant effects
BM050  Increased risk of bleeding
BM064  Increased risk of hypoglycemia
BM069  Increased risk of lowers seizure threshold
BM075  Increased risk of photosensitivity reactions
BM080  Increased risk of tendinitis/tendon rupture
BM086  Antagonize the effect of antidiabetic agents
BM089  Antagonize the effect of antihypertensive agents
BM100  Antagonize the effect of vaccine/toxoid
BM107  Attenuated pharmacological effects (Unspecific)
  Relation Graph
 Full list of drugs interacting with Enoxacin
      Affected gastrointestinal absorption
   Altered intestinal flora Drug Num:  2
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D1094
 
Mycophenolate mofetil
 
C23H31NO7
 
5281078 
Moderate    Inter Info   
[178], [179]
D1095
 
Mycophenolic acid
 
C17H20O6
 
446541 
Moderate    Inter Info   
[178], [179]
   Complex formation Drug Num:  30
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D0235
 
Calcium acetate
 
C4H6CaO4
 
6116 
Moderate    Inter Info   
[96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [4], [113], [6], [93], [114], [115], [116], [117], [118], [119], [120], [121], [122], [123], [124]
D0049
 
Aluminum hydroxide
 
AlH3O3
 
10176082 
Moderate    Inter Info   
[96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [4], [113], [6], [93], [114], [115], [116], [117], [118], [119], [120], [121], [122], [123], [124]
D0236
 
Calcium carbonate
 
CCaO3
 
10112 
Moderate    Inter Info   
[109], [110], [120]
D0238
 
Calcium citrate
 
C12H10Ca3O14
 
13136 
Moderate    Inter Info   
[96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [4], [113], [6], [93], [114], [115], [116], [117], [118], [119], [120], [121], [122], [123], [124]
D0239
 
Calcium glubionate anhydrous
 
C18H32CaO19
 
64776 
Moderate    Inter Info   
[109], [110], [120]
D0241
 
Calcium gluconate
 
C12H22CaO14
 
9290 
Moderate    Inter Info   
[96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [4], [113], [6], [93], [114], [115], [116], [117], [118], [119], [120], [121], [122], [123], [124]
D0243
 
Calcium lactate
 
C6H10CaO6
 
13144 
Moderate    Inter Info   
[96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [4], [113], [6], [93], [114], [115], [116], [117], [118], [119], [120], [121], [122], [123], [124]
D0244
 
Calcium Phosphate
 
Ca3O8P2
 
24456 
Moderate    Inter Info   
[109], [110], [120]
D0483
 
Didanosine
 
C10H12N4O3
 
135398739 
Moderate    Inter Info   
[148], [101], [149], [150], [151], [90], [139], [152], [153], [154], [155]
D0619
 
Ethinylestradiol
 
C20H24O2
 
5991 
Moderate    Inter Info   
[157], [158], [159]
D0649
 
Ferrous fumarate
 
C4H2FeO4
 
6433164 
Moderate    Inter Info   
[96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [4], [113], [6], [93], [114], [115], [116], [117], [118], [119], [120], [121], [122], [123], [124]
D0650
 
Ferrous gluconate
 
C12H22FeO14
 
23616740 
Moderate    Inter Info   
[96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [4], [113], [6], [93], [114], [115], [116], [117], [118], [119], [120], [121], [122], [123], [124]
D0651
 
Ferrous sulfate anhydrous
 
FeO4S
 
24393 
Moderate    Inter Info   
[109], [110], [120]
D0877
 
Kaolin
 
Al2H4O9Si2
 
56841936 
Moderate    Inter Info   
[109], [110], [120]
D0893
 
Lanthanum carbonate
 
C3La2O9
 
168924 
Moderate    Inter Info   
[34], [58], [56], [169], [170], [171]
D0968
 
Magnesium carbonate
 
CMgO3
 
11029 
Moderate    Inter Info   
[109], [110], [120]
D0969
 
Magnesium chloride
 
Cl2H12MgO6
 
643991 
Moderate    Inter Info   
[96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [4], [113], [6], [93], [114], [115], [116], [117], [118], [119], [120], [121], [122], [123], [124]
D0970
 
Magnesium citrate
 
C12H10Mg3O14
 
6099959 
Moderate    Inter Info   
[96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [4], [113], [6], [93], [114], [115], [116], [117], [118], [119], [120], [121], [122], [123], [124]
D0971
 
Magnesium gluconate
 
C12H22MgO14
 
11418570 
Moderate    Inter Info   
[96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [4], [113], [6], [93], [114], [115], [116], [117], [118], [119], [120], [121], [122], [123], [124]
D0973
 
Magnesium hydroxide
 
H2MgO2
 
14791 
Moderate    Inter Info   
[96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [4], [113], [6], [93], [114], [115], [116], [117], [118], [119], [120], [121], [122], [123], [124]
D0974
 
Magnesium oxide
 
MgO
 
14792 
Moderate    Inter Info   
[96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [4], [113], [6], [93], [114], [115], [116], [117], [118], [119], [120], [121], [122], [123], [124]
D0975
 
Magnesium sulfate
 
MgO4S
 
24083 
Moderate    Inter Info   
[96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [4], [113], [6], [93], [114], [115], [116], [117], [118], [119], [120], [121], [122], [123], [124]
D1011
 
Mestranol
 
C21H26O2
 
6291 
Moderate    Inter Info   
[157], [158], [159]
D1456
 
Selenium
 
Se
 
6326970 
Moderate    Inter Info   
[96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [4], [113], [6], [93], [114], [115], [116], [117], [118], [119], [120], [121], [122], [123], [124]
D1462
 
Sevelamer
 
C6H12ClNO
 
3085017 
Moderate    Inter Info   
[189]
D1566
 
Tetraferric tricitrate decahydrate
 
C18H32Fe4O31
 
90478690 
Moderate    Inter Info   
[109], [110], [120]
D1722
 
Zinc acetate
 
C4H6O4Zn
 
11192 
Moderate    Inter Info   
[96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [4], [113], [6], [93], [114], [115], [116], [117], [118], [119], [120], [121], [122], [123], [124]
D1724
 
Zinc gluconate
 
C12H22O14Zn
 
443445 
Moderate    Inter Info   
[96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [4], [113], [6], [93], [114], [115], [116], [117], [118], [119], [120], [121], [122], [123], [124]
D1725
 
Zinc sulfate
 
O4SZn
 
24424 
Moderate    Inter Info   
[96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [4], [113], [6], [93], [114], [115], [116], [117], [118], [119], [120], [121], [122], [123], [124]
D1511
 
Sucralfate
 
C12H54Al9O55S8
 
121494085 
Moderate    Inter Info   
[96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [4], [113], [6], [93], [114], [115], [116], [117], [118], [119], [120], [121], [122], [123], [124]
   Altered gastric pH Drug Num:  4
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D0337
 
Cimetidine
 
C10H16N6S
 
2756 
Minor    Inter Info   
[204], [205]
D0636
 
Famotidine
 
C8H15N7O2S3
 
5702160 
Minor    Inter Info   
[204], [205]
D1151
 
Nizatidine
 
C12H21N5O2S2
 
3033637 
Minor    Inter Info   
[204], [205]
D1381
 
Ranitidine
 
C13H22N4O3S
 
3001055 
Minor    Inter Info   
[204], [205]
   Altered intestinal mucosa Drug Num:  52
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D0030
 
Aldesleukin
 
NA
 
NA
Minor    Inter Info   
[172]
D0190
 
Bleomycin
 
C55H84N17O21S3+
 
5360373 
Minor    Inter Info   
[172]
D0264
 
Carmustine
 
C5H9Cl2N3O2
 
2578 
Minor    Inter Info   
[172]
D0312
 
Chlorambucil
 
C14H19Cl2NO2
 
2708 
Minor    Inter Info   
[172]
D0442
 
Denileukin diftitox
 
NA
 
NA
Minor    Inter Info   
[172]
D0048
 
Altretamine
 
C9H18N6
 
2123 
Minor    Inter Info   
[172]
D0223
 
Busulfan
 
C6H14O6S2
 
2478 
Minor    Inter Info   
[172]
D0249
 
Capecitabine
 
C15H22FN3O6
 
60953 
Minor    Inter Info   
[172]
D0260
 
Carboplatin
 
C6H12N2O4Pt
 
426756 
Minor    Inter Info   
[172]
D0344
 
Cisplatin
 
Cl2H6N2Pt
 
5702198 
Minor    Inter Info   
[172]
D0357
 
Clofarabine
 
C10H11ClFN5O3
 
119182 
Minor    Inter Info   
[172]
D0400
 
Cyclophosphamide
 
C7H15Cl2N2O2P
 
2907 
Minor    Inter Info   
[172]
D0404
 
Cytarabine
 
C9H13N3O5
 
6253 
Minor    Inter Info   
[172]
D0407
 
Dacarbazine
 
C6H10N6O
 
135398738 
Minor    Inter Info   
[172]
D0410
 
Dactinomycin
 
C62H86N12O16
 
457193 
Minor    Inter Info   
[172]
D0429
 
Daunorubicin
 
C27H29NO10
 
30323 
Minor    Inter Info   
[172]
D0430
 
Daunorubicin (liposomal)
 
C27H29NO10
 
30323 
Minor    Inter Info   
[172]
D0511
 
Docetaxel
 
C43H53NO14
 
148124 
Minor    Inter Info   
[172]
D0528
 
Doxorubicin
 
C27H29NO11
 
31703 
Minor    Inter Info   
[172]
D0627
 
Etoposide
 
C29H32O13
 
36462 
Minor    Inter Info   
[172]
D0669
 
Fludarabine
 
C10H12FN5O4
 
657237 
Minor    Inter Info   
[172]
D0675
 
Fluorouracil
 
C4H3FN2O2
 
3385 
Minor    Inter Info   
[172]
D0780
 
Hydroxyurea
 
CH4N2O2
 
3657 
Minor    Inter Info   
[172]
D0788
 
Idarubicin
 
C26H27NO9
 
42890 
Minor    Inter Info   
[172]
D0790
 
Ifosfamide
 
C7H15Cl2N2O2P
 
3690 
Minor    Inter Info   
[172]
D0845
 
Irinotecan
 
C33H38N4O6
 
60838 
Minor    Inter Info   
[172]
D0945
 
Lomustine
 
C9H16ClN3O2
 
3950 
Minor    Inter Info   
[172]
D0962
 
Lurbinectedin
 
C41H44N4O10S
 
57327016 
Minor    Inter Info   
[172]
D0986
 
Mechlorethamine
 
C5H11Cl2N
 
4033 
Minor    Inter Info   
[172]
D0996
 
Melphalan
 
C13H18Cl2N2O2
 
460612 
Minor    Inter Info   
[172]
D1007
 
Mercaptopurine
 
C5H4N4S
 
667490 
Minor    Inter Info   
[172]
D1079
 
Mitoxantrone
 
C22H28N4O6
 
4212 
Minor    Inter Info   
[172]
D1212
 
Paclitaxel
 
C47H51NO14
 
36314 
Minor    Inter Info   
[172]
D1213
 
Paclitaxel (protein-bound)
 
C47H51NO14
 
36314 
Minor    Inter Info   
[172]
D1250
 
Pentostatin
 
C11H16N4O4
 
439693 
Minor    Inter Info   
[172]
D1345
 
Procarbazine
 
C12H19N3O
 
4915 
Minor    Inter Info   
[172]
D1548
 
Temozolomide
 
C6H6N6O2
 
5394 
Minor    Inter Info   
[172]
D1575
 
Thiotepa
 
C6H12N3PS
 
5453 
Minor    Inter Info   
[172]
D1610
 
Topotecan
 
C23H23N3O5
 
60700 
Minor    Inter Info   
[172]
D1626
 
Tretinoin
 
C20H28O2
 
444795 
Minor    Inter Info   
[172]
D1697
 
Vinblastine
 
C46H58N4O9
 
13342 
Minor    Inter Info   
[172]
D1698
 
Vincristine
 
C46H56N4O10
 
5978 
Minor    Inter Info   
[172]
D1699
 
Vincristine (liposome)
 
C46H56N4O10
 
5978 
Minor    Inter Info   
[172]
D0584
 
Epirubicin
 
C27H29NO11
 
41867 
Minor    Inter Info   
[172]
D0666
 
Floxuridine
 
C9H11FN2O5
 
5790 
Minor    Inter Info   
[172]
D0714
 
Gemcitabine
 
C9H11F2N3O4
 
60750 
Minor    Inter Info   
[172]
D0717
 
Gemtuzumab ozogamicin
 
NA
 
NA
Minor    Inter Info   
[172]
D1077
 
Mitomycin
 
C15H18N4O5
 
5746 
Minor    Inter Info   
[172]
D1508
 
Streptozocin
 
C8H15N3O7
 
29327 
Minor    Inter Info   
[172]
D1551
 
Teniposide
 
C32H32O13S
 
452548 
Minor    Inter Info   
[172]
D1589
 
Tioguanine
 
C5H5N5S
 
2723601 
Minor    Inter Info   
[172]
D1700
 
Vinorelbine
 
C45H54N4O8
 
5311497 
Minor    Inter Info   
[172]
      Affected organization distribution
   Interference of cell/tissue uptake Drug Num:  1
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D1817
 
Indium In-111 oxyquinoline
 
C27H18InN3O3
 
16685037 
Moderate    Inter Info   
[168]
      Affected intra/extra-hepatic metabolism
   CYP450 enzyme inhibition Drug Num:  26
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D0370
 
Clozapine
 
C18H19ClN4
 
135398737 
Major    Inter Info   
[8], [9], [10], [11]
D0064
 
Aminophylline
 
C16H24N10O4
 
9433 
Major    Inter Info   
[12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29]
D0539
 
Duloxetine
 
C18H19NOS
 
60835 
Major    Inter Info   
[49], [50]
D1299
 
Pirfenidone
 
C12H11NO
 
40632 
Major    Inter Info   
[56], [57]
D1385
 
Rasagiline
 
C12H13N
 
3052776 
Major    Inter Info   
[58], [56], [59]
D1536
 
Tasimelteon
 
C15H19NO2
 
10220503 
Major    Inter Info   
[60]
D1596
 
Tizanidine
 
C9H8ClN5S
 
5487 
Major    Inter Info   
[61], [62], [63], [64], [65], [66], [67], [68]
D1570
 
Theophylline
 
C7H8N4O2
 
2153 
Major    Inter Info   
[12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29]
D0084
 
Anagrelide
 
C10H7Cl2N3O
 
135409400 
Moderate    Inter Info   
[80]
D0231
 
Caffeine
 
C8H10N4O2
 
2519 
Moderate    Inter Info   
[81], [82], [83], [84], [85], [86], [87], [9], [88], [89], [90], [5], [91], [92], [93], [94], [95]
D0535
 
Droperidol
 
C22H22FN3O2
 
3168 
Moderate    Inter Info   
[125], [126], [58], [56], [127], [128], [129]
D0043
 
Alosetron
 
C17H18N4O
 
2099 
Moderate    Inter Info   
[131]
D0112
 
Asenapine
 
C17H16ClNO
 
3036780 
Moderate    Inter Info   
[135]
D0157
 
Bendamustine
 
C16H21Cl2N3O2
 
65628 
Moderate    Inter Info   
[137]
D0324
 
Chlorpromazine
 
C17H19ClN2S
 
2726 
Moderate    Inter Info   
[58], [56], [146]
D0562
 
Eluxadoline
 
C32H35N5O5
 
11250029 
Moderate    Inter Info   
[156]
D1251
 
Pentoxifylline
 
C13H18N4O3
 
4740 
Moderate    Inter Info   
[181], [182]
D1292
 
Pimozide
 
C28H29F2N3O
 
16362 
Moderate    Inter Info   
[183], [184]
D1378
 
Ramelteon
 
C16H21NO2
 
208902 
Moderate    Inter Info   
[186]
D1422
 
Roflumilast
 
C17H14Cl2F2N2O3
 
449193 
Moderate    Inter Info   
[56], [187], [188]
D1505
 
Stiripentol
 
C14H18O3
 
5311454 
Moderate    Inter Info   
[56], [190], [191]
D1075
 
Mirtazapine
 
C17H19N3
 
4205 
Moderate    Inter Info   
[196], [197], [198], [199], [200]
D1427
 
Ropinirole
 
C16H24N2O
 
5095 
Moderate    Inter Info   
[91], [201]
D1405
 
Riluzole
 
C8H5F3N2OS
 
5070 
Minor    Inter Info   
[208], [116]
D1054
 
Mexiletine
 
C11H17NO
 
4178 
Minor    Inter Info   
[209], [210]
D1166
 
Olanzapine
 
C17H20N4S
 
135398745 
Minor    Inter Info   
[211], [212], [213], [214], [56], [215], [216], [217], [218], [219], [220], [221], [222], [223], [224], [225], [226], [227]
      Affected excretion pathways
   Competitive inhibition of renal tubular secretion Drug Num:  8
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D1025
 
Methotrexate
 
C20H22N8O5
 
126941 
Moderate    Inter Info   
[172], [173], [174]
D1241
 
Pemetrexed
 
C20H21N5O6
 
135410875 
Moderate    Inter Info   
[180]
D0576
 
Entecavir
 
C12H15N5O3
 
135398508 
Moderate    Inter Info   
[192]
D0217
 
Bumetanide
 
C17H20N2O5S
 
2471 
Minor    Inter Info   
[203]
D0613
 
Etacrynic acid
 
C13H12Cl2O4
 
3278 
Minor    Inter Info   
[203]
D0704
 
Furosemide
 
C12H11ClN2O5S
 
3440 
Minor    Inter Info   
[203]
D1341
 
Probenecid
 
C13H19NO4S
 
4911 
Minor    Inter Info   
[113], [206], [207]
D1611
 
Torasemide
 
C16H20N4O3S
 
41781 
Minor    Inter Info   
[203]
   Altered urine pH Drug Num:  3
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D1760
 
Citric acid
 
C6H8O7
 
311 
Moderate    Inter Info   
[147], [5]
D1319
 
Potassium citrate
 
C6H5K3O7
 
13344 
Moderate    Inter Info   
[147], [5]
D1483
 
Sodium citrate
 
C6H5Na3O7
 
6224 
Moderate    Inter Info   
[147], [5]
      Pharmacodynamic additive effects
   Additive CNS depression effects Drug Num:  10
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D0298
 
Celecoxib
 
C17H14F3N3O2S
 
2662 
Moderate    Inter Info   
[113], [93], [5], [3], [138], [139], [130], [140], [141], [142], [143], [144], [145], [6]
D0476
 
Diclofenac
 
C14H11Cl2NO2
 
3033 
Moderate    Inter Info   
[113], [93], [5], [3], [138], [139], [130], [140], [141], [142], [143], [144], [145], [6]
D0489
 
Diflunisal
 
C13H8F2O3
 
3059 
Moderate    Inter Info   
[113], [93], [5], [3], [138], [139], [130], [140], [141], [142], [143], [144], [145], [6]
D0624
 
Etodolac
 
C17H21NO3
 
3308 
Moderate    Inter Info   
[113], [93], [5], [3], [138], [139], [130], [140], [141], [142], [143], [144], [145], [6]
D0645
 
Fenoprofen
 
C15H14O3
 
3342 
Moderate    Inter Info   
[113], [93], [5], [3], [138], [139], [130], [140], [141], [142], [143], [144], [145], [6]
D0680
 
Flurbiprofen
 
C15H13FO2
 
3394 
Moderate    Inter Info   
[113], [93], [5], [3], [138], [139], [130], [140], [141], [142], [143], [144], [145], [6]
D0786
 
Ibuprofen
 
C13H18O2
 
3672 
Moderate    Inter Info   
[113], [93], [5], [3], [138], [139], [130], [140], [141], [142], [143], [144], [145], [6]
D0881
 
Ketoprofen
 
C16H14O3
 
3825 
Moderate    Inter Info   
[113], [93], [5], [3], [138], [139], [130], [140], [141], [142], [143], [144], [145], [6]
D0800
 
Indomethacin
 
C19H16ClNO4
 
3715 
Moderate    Inter Info   
[113], [93], [5], [3], [138], [139], [130], [140], [141], [142], [143], [144], [145], [6]
D0882
 
Ketorolac
 
C15H13NO3
 
3826 
Moderate    Inter Info   
[113], [93], [5], [3], [138], [139], [130], [140], [141], [142], [143], [144], [145], [6]
   Additive CNS stimulant effects Drug Num:  12
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D0017
 
Acetylsalicylic acid
 
C9H8O4
 
2244 
Moderate    Inter Info   
[130], [3], [113]
D0331
 
Choline salicylate
 
C12H19NO4
 
54686350 
Moderate    Inter Info   
[130], [3], [113]
D0988
 
Meclofenamic acid
 
C14H11Cl2NO2
 
4037 
Moderate    Inter Info   
[130], [3], [113]
D0991
 
Mefenamic acid
 
C15H15NO2
 
4044 
Moderate    Inter Info   
[113], [93], [5], [3], [138], [139], [130], [140], [141], [142], [143], [144], [145], [6]
D1109
 
Naproxen
 
C14H14O3
 
156391 
Moderate    Inter Info   
[113], [93], [5], [3], [138], [139], [130], [140], [141], [142], [143], [144], [145], [6]
D1196
 
Oxaprozin
 
C18H15NO3
 
4614 
Moderate    Inter Info   
[113], [93], [5], [3], [138], [139], [130], [140], [141], [142], [143], [144], [145], [6]
D1272
 
Phenyl salicylate
 
C13H10O3
 
8361 
Moderate    Inter Info   
[130], [3], [113]
D1300
 
Piroxicam
 
C15H13N3O4S
 
54676228 
Moderate    Inter Info   
[113], [93], [5], [3], [138], [139], [130], [140], [141], [142], [143], [144], [145], [6]
D1442
 
Salsalate
 
C14H10O5
 
5161 
Moderate    Inter Info   
[113], [93], [5], [3], [138], [139], [130], [140], [141], [142], [143], [144], [145], [6]
D1520
 
Sulindac
 
C20H17FO3S
 
1548887 
Moderate    Inter Info   
[113], [93], [5], [3], [138], [139], [130], [140], [141], [142], [143], [144], [145], [6]
D1606
 
Tolmetin
 
C15H15NO3
 
5509 
Moderate    Inter Info   
[113], [93], [5], [3], [138], [139], [130], [140], [141], [142], [143], [144], [145], [6]
D1097
 
Nabumetone
 
C15H16O2
 
4409 
Moderate    Inter Info   
[113], [93], [5], [3], [138], [139], [130], [140], [141], [142], [143], [144], [145], [6]
   Increased risk of bleeding Drug Num:  1
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D1711
 
Warfarin
 
C19H16O4
 
54678486 
Major    Inter Info   
[72], [73], [74]
   Increased risk of hypoglycemia Drug Num:  16
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D0009
 
Acarbose
 
C25H43NO18
 
41774 
Moderate    Inter Info   
[77], [78], [79]
D0029
 
Albiglutide
 
C148H224N40O45
 
145994868 
Moderate    Inter Info   
[77], [78], [79]
D0042
 
Alogliptin
 
C18H21N5O2
 
11450633 
Moderate    Inter Info   
[77], [78], [79]
D0245
 
Canagliflozin
 
C24H25FO5S
 
24812758 
Moderate    Inter Info   
[77], [78], [79]
D0418
 
Dapagliflozin
 
C21H25ClO6
 
9887712 
Moderate    Inter Info   
[77], [78], [79]
D0565
 
Empagliflozin
 
C23H27ClO7
 
11949646 
Moderate    Inter Info   
[77], [78], [79]
D0930
 
Linagliptin
 
C25H28N8O2
 
10096344 
Moderate    Inter Info   
[77], [78], [79]
D0936
 
Liraglutide
 
C172H265N43O51
 
16134956 
Moderate    Inter Info   
[77], [78], [79]
D0941
 
Lixisenatide
 
C215H347N61O65S
 
90472060 
Moderate    Inter Info   
[77], [78], [79]
D1064
 
Miglitol
 
C8H17NO5
 
441314 
Moderate    Inter Info   
[77], [78], [79]
D1294
 
Pioglitazone
 
C19H20N2O3S
 
4829 
Moderate    Inter Info   
[77], [78], [79]
D1326
 
Pramlintide
 
C171H267N51O53S2
 
70691388 
Moderate    Inter Info   
[77], [78], [79]
D1449
 
Saxagliptin
 
C18H25N3O2
 
11243969 
Moderate    Inter Info   
[77], [78], [79]
D1477
 
Sitagliptin
 
C16H15F6N5O
 
4369359 
Moderate    Inter Info   
[77], [78], [79]
D1015
 
Metformin
 
C4H11N5
 
4091 
Moderate    Inter Info   
[77], [78], [79]
D1429
 
Rosiglitazone
 
C18H19N3O3S
 
77999 
Moderate    Inter Info   
[77], [78], [79]
   Increased risk of lowers seizure threshold Drug Num:  9
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D0220
 
Bupropion
 
C13H18ClNO
 
444 
Major    Inter Info   
[32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46]
D0833
 
Iohexol
 
C19H26I3N3O9
 
3730 
Major    Inter Info   
[51], [52], [53], [54], [55]
D0834
 
Iopamidol
 
C17H22I3N3O8
 
65492 
Major    Inter Info   
[51], [52], [53], [54], [55]
D1616
 
Tramadol
 
C16H25NO2
 
33741 
Major    Inter Info   
[75], [45], [44], [76]
D0054
 
Amifampridine
 
C5H7N3
 
5918 
Moderate    Inter Info   
[132], [133]
D0678
 
Fluphenazine
 
C22H26F3N3OS
 
3372 
Moderate    Inter Info   
[58], [56]
D0722
 
Ginkgo biloba
 
NA
 
NA
Moderate    Inter Info   
[160], [161], [162], [163], [164], [165], [166], [167]
D1308
 
Polyethylene glycol (3350 with electrolytes)
 
C2H6O2
 
174 
Moderate    Inter Info   
[114], [185], [56]
D0932
 
Lindane
 
C6H6Cl6
 
727 
Moderate    Inter Info   
[193], [194], [195]
   Increased risk of photosensitivity reactions Drug Num:  4
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D0063
 
Aminolevulinic acid (topical)
 
C5H9NO3
 
137 
Moderate    Inter Info   
[58], [56], [134]
D1028
 
Methoxsalen
 
C12H8O4
 
4114 
Moderate    Inter Info   
[58], [147], [175], [176], [177]
D1033
 
Methyl aminolevulinate (topical)
 
C6H11NO3
 
157922 
Moderate    Inter Info   
[58], [56], [134]
D1691
 
Verteporfin
 
C82H84N8O16
 
11980904 
Moderate    Inter Info   
[56], [147], [175], [202]
   Increased risk of tendinitis/tendon rupture Drug Num:  10
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D0172
 
Betamethasone
 
C22H29FO5
 
9782 
Major    Inter Info   
[1], [2], [3], [4], [5], [6], [7]
D0155
 
Bempedoic acid
 
C19H36O5
 
10472693 
Major    Inter Info   
[30], [31]
D0436
 
Deflazacort
 
C25H31NO6
 
189821 
Major    Inter Info   
[1], [2], [3], [4], [5], [6], [7]
D0453
 
Dexamethasone
 
C22H29FO5
 
5743 
Major    Inter Info   
[1], [2], [3], [4], [5], [6], [7]
D0671
 
Fludrocortisone
 
C21H29FO5
 
31378 
Major    Inter Info   
[1], [2], [3], [4], [5], [6], [7]
D0773
 
Hydrocortisone
 
C21H30O5
 
5754 
Major    Inter Info   
[1], [2], [3], [4], [5], [6], [7]
D1041
 
Methylprednisolone
 
C22H30O5
 
6741 
Major    Inter Info   
[1], [2], [3], [4], [5], [6], [7]
D1332
 
Prednisolone
 
C21H28O5
 
5755 
Major    Inter Info   
[1], [2], [3], [4], [5], [6], [7]
D1334
 
Prednisone
 
C21H26O5
 
5865 
Major    Inter Info   
[1], [2], [3], [4], [5], [6], [7]
D1628
 
Triamcinolone
 
C21H27FO6
 
31307 
Major    Inter Info   
[1], [2], [3], [4], [5], [6], [7]
      Pharmacodynamic antagonistic effects
   Antagonize the effect of antidiabetic agents Drug Num:  19
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D0325
 
Chlorpropamide
 
C10H13ClN2O3S
 
2727 
Major    Inter Info   
[47], [5], [48]
D0728
 
Glipizide
 
C21H27N5O4S
 
3478 
Major    Inter Info   
[47], [5], [48]
D0730
 
Glyburide
 
C23H28ClN3O5S
 
3488 
Major    Inter Info   
[47], [5], [48]
D0808
 
Insulin aspart (aspart)
 
C256H381N65O79S6
 
118984445 
Major    Inter Info   
[47], [5], [48]
D0809
 
Insulin degludec
 
C274H411N65O81S6
 
118984462 
Major    Inter Info   
[47], [5], [48]
D0810
 
Insulin detemir
 
C267H402N64O76S6
 
16137271 
Major    Inter Info   
[47], [5], [48]
D0812
 
Insulin glulisine
 
C258H384N64O78S6
 
16136701 
Major    Inter Info   
[47], [5], [48]
D1112
 
Nateglinide
 
C19H27NO3
 
5311309 
Major    Inter Info   
[47], [5], [48]
D1392
 
Repaglinide
 
C27H36N2O4
 
65981 
Major    Inter Info   
[47], [5], [48]
D1601
 
Tolazamide
 
C14H21N3O3S
 
5503 
Major    Inter Info   
[47], [5], [48]
D1603
 
Tolbutamide
 
C12H18N2O3S
 
5505 
Major    Inter Info   
[47], [5], [48]
D0727
 
Glimepiride
 
C24H34N4O5S
 
3476 
Major    Inter Info   
[47], [5], [48]
D0811
 
Insulin glargine
 
C267H404N72O78S6
 
118984454 
Major    Inter Info   
[47], [5], [48]
D0814
 
Insulin human (inhalation, rapid acting)
 
C257H383N65O77S6
 
118984375 
Major    Inter Info   
[47], [5], [48]
D0815
 
Insulin human (isophane)
 
C257H383N65O77S6
 
118984375 
Major    Inter Info   
[47], [5], [48]
D0816
 
Insulin human (regular)
 
C257H383N65O77S6
 
118984375 
Major    Inter Info   
[47], [5], [48]
D0817
 
Insulin human (zinc extended)
 
C257H383N65O77S6
 
118984375 
Major    Inter Info   
[47], [5], [48]
D0818
 
Insulin human (zinc)
 
C257H383N65O77S6
 
118984375 
Major    Inter Info   
[47], [5], [48]
D0819
 
Insulin lispro
 
C257H389N65O77S6
 
16132438 
Major    Inter Info   
[47], [5], [48]
   Antagonize the effect of antihypertensive agents Drug Num:  4
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D1779
 
Dulaglutide
 
NA
 
NA
Moderate    Inter Info   
[77], [78], [79]
D1782
 
Ertugliflozin
 
C22H25ClO7
 
44814423 
Moderate    Inter Info   
[77], [78], [79]
D1784
 
Exenatide
 
C184H282N50O60S
 
45588096 
Moderate    Inter Info   
[77], [78], [79]
D1887
 
Semaglutide
 
C187H291N45O59
 
56843331 
Moderate    Inter Info   
[77], [78], [79]
   Antagonize the effect of vaccine/toxoid Drug Num:  2
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D1914
 
Typhoid vaccine (live)
 
NA
 
NA
Major    Inter Info   
[56], [69], [70]
D1693
 
Vibrio cholerae CVD 103-HgR strain live antigen (live)
 
NA
 
NA
Major    Inter Info   
[71]
   Attenuated pharmacological effects (Unspecific) Drug Num:  1
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D0145
 
Balsalazide
 
C17H15N3O6
 
54585 
Moderate    Inter Info   
[136]
References
1 FDA. U.S. Food and Drug Administration "Information for Healthcare Professionals. Fluoroquinolone Antimicrobial Drugs. FDA Alert [7/8/2008].".
2 Khaliq Y, Zhanel GG "Fluoroquinolone-Associated Tendinopathy: A Critical Review of the Literature." Clin Infect Dis 36 (2003): 1404-1410. [PMID: 12766835]
3 Product Information. Avelox (moxifloxacin) Bayer, West Haven, CT.
4 Product Information. Baxdela (delafloxacin). Melinta Therapeutics, Lincolnshire, IL.
5 Product Information. Cipro (ciprofloxacin). Bayer, West Haven, CT.
6 Product Information. Levaquin (levofloxacin). Ortho Pharmaceutical Corporation, Raritan, NJ.
7 van der Linden PD, Sturkenboom MC, Herings RM, Leufkens HM, Rowlands S, Stricker BH "Increased risk of achilles tendon rupture with quinolone antibacterial use, especially in elderly patients taking oral corticosteroids." Arch Intern Med 163 (2003): 1801-7. [PMID: 12912715]
8 Fuhr U, Anders EM, Mahr G, Sorgel F, Staid AH "Inhibitory potency of quinolone antibacterial agents against cytochrome P450IA2 activity in vivo and in vitro." Antimicrob Agents Chemother 36 (1992): 942-8. [PMID: 1510417]
9 Kinzig-Schippers M, Fuhr U, Zaigler M, et al "Interaction of pefloxacin and enoxacin with the human cytochrome P450 enzyme CYP1A2." Clin Pharmacol Ther 65 (1999): 262-74. [PMID: 10096258]
10 Markowitz JS, Gill HS, Devane CL, Mintzer JE "Fluoroquinolone inhibition of clozapine metabolism." Am J Psychiatry 154 (1997): 881. [PMID: 9167522]
11 Raaska K, Neuvonen PJ "Ciprofloxacin increases serum clozapine and N-desmethylclozapine: a study in patients with schizophrenia." Eur J Clin Pharmacol 56 (2000): 585-9. [PMID: 11151749]
12 Beckmann J, Elsaber W, Gundert-Remy U, Hertrampf R "Enoxacin: a potent inhibitor of theophylline metabolism." Eur J Clin Pharmacol 33 (1987): 227-30. [PMID: 3480222]
13 Hardman JG, Gilman AG, Limbird LE eds. "Goodman and Gilman's the Pharmacological Basis of Therapeutics. 9th ed." New York, NY: McGraw-Hill (1995):.
14 Harris JM "Drug interaction affecting theophylline clearance." J Pediatr 116 (1990): 838-9. [PMID: 2329438]
15 Koup JR, Toothaker RD, Posvar E, et al "Theophylline dosage adjustment during enoxacin coadministration." Antimicrob Agents Chemother 34 (1990): 803-7. [PMID: 2360819]
16 Rogge MC, Solomon WR, Sedman AJ, et al "The theophylline-enoxacin interaction. I: effect of enoxacin dose size on theophylline disposition." Clin Pharmacol Ther 44 (1988): 579-87. [PMID: 3180639]
17 Rogge MC, Solomon WR, Sedman AJ, et al "The theophylline-enoxacin interaction. II: Changes in the disposition of theophylline and its metabolites during intermittent administration of enoxacin." Clin Pharmacol Ther 46 (1989): 420-8. [PMID: 2791445]
18 Sana M, Kawakatsu K, Ohkita C, et al "Effects of enoxacin, ofloxacin and norfloxacin on theophylline disposition in humans." Eur J Clin Pharmacol 35 (1988): 161-5. [PMID: 3191935]
19 Sano M, Kawakatsu K, Yamamoto I, et al "Inhibitory effect of enoxacin, ofloxacin and norfloxacin on renal excretion of theophylline in humans." Eur J Clin Pharmacol 36 (1989): 323-4. [PMID: 2744074]
20 Sijnands WJ, Vree TB, Baars AM, Van Herwaarden CL "Steady-state kinetics of the quinolone derivatives ofloxacin, enoxacin, ciprofloxacin and pefloxacin during maintenance treatment with theopylline." Drugs 34 (1987): 159-69. [PMID: 3481317]
21 Sorgel F, Mahr G, Granneman GR, et al "Effects of 2 quinolone antibacterials, temafloxacin and enoxacin, on theophylline pharmacokinetics." Clin Pharmacokinet 22 (1992): 65-74. [PMID: 1319873]
22 Takagi K, Hasegawa T, Ogura Y, et al "Comparative studies on interaction between theophylline and quinolones." J Asthma 25 (1988): 63-70. [PMID: 3182580]
23 Takagi K, Hasegawa T, Yamaki K, et al "Interaction between theophylline and enoxacin." Int J Clin Pharmacol Ther Toxicol 26 (1988): 288-92. [PMID: 3165968]
24 Upton RA "Pharmacokinetic interactions between theophylline and other medication (Part I)." Clin Pharmacokinet 20 (1991): 66-80. [PMID: 1674242]
25 Wijnands GJ, Vree TB, Janssen TJ, Guelen PJ "Drug-drug interactions affecting fluoroquinolones." Am J Med 87 (1989): s47-51. [PMID: 2603893]
26 Wijnands WJ, Van Herwaarden CL "Enoxacin raises plasma theophylline concentrations." Lancet 2 (1984): 108-9. [PMID: 6145999]
27 Wijnands WJ, Vree TB "Interaction between the fluoroquinolones and the bronchodilator theophylline." J Antimicrob Chemother 22 (1988): 109-14. [PMID: 3053575]
28 Wijnands WJ, Vree TB, Baars AM, van Herwaarden CL "Steady-state kinetics of the quinolone derivatives ofloxacin, enoxacin, ciprofloxacin and pefloxacin during maintneance treatment with theophylline." Drugs 34 (1987): 159-69. [PMID: 3481317]
29 Wijnands WJ, Vree TB, van Herwaarden CL "Enoxacin decreases the clearance of theophylline in man." Br J Clin Pharmacol 20 (1985): 583-8. [PMID: 3867394]
30 Product Information. Nexletol (bempedoic acid). Esperion Therapeutics, Ann Arbor, MI.
31 Product Information. Nexlizet (bempedoic acid-ezetimibe). Esperion Therapeutics, Ann Arbor, MI.
32 Product Information. Wellbutrin XL (buPROPion). GlaxoSmithKline, Philadelphia, PA.
33 Sheehan DV, Welch JB, Fishman SM "A case of bupropion-induced seizure." J Nerv Ment Dis 174 (1986): 496-8. [PMID: 3090199]
34 Canadian Pharmacists Association.
35 Product Information. Wellbutrin (bupropion). Glaxo Wellcome, Research Triangle Park, NC.
36 Gittelman DK, Kirby MG "A seizure following bupropion overdose." J Clin Psychiatry 54 (1993): 162. [PMID: 8486598]
37 Product Information. Wellbutrin SR (bupropion). Glaxo Wellcome, Research Triangle Park, NC.
38 James WA, Lippmann S "Bupropion: overview and prescribing guidelines in depression." South Med J 84 (1991): 222-4. [PMID: 1899294]
39 Masco HL, Kiev A, Holloman LC, Batey SR, Johnston JA, Lineberry CG "Safety and efficacy of bupropion and nortriptyline in outpatients with depression." Curr Ther Res Clin Exp 55 (1994): 851-63.
40 Dufresne RL, Weber SS, Becker RE "Bupropion hydrochloride." Drug Intell Clin Pharm 18 (1984): 957-64. [PMID: 6439541]
41 Product Information. Zyban (bupropion). Glaxo Wellcome, Research Triangle Park, NC.
42 Storrow AB "Bupropion overdose and seizure." Am J Emerg Med 12 (1994): 183-4. [PMID: 8161393]
43 Johnston JA, Lineberry CG, Ascher JA, et al. "A 102-center prospective study of seizure in association with bupropion." J Clin Psychiatry 52 (1991): 450-6. [PMID: 1744061]
44 Rosenstein DL, Nelson JC, Jacobs SC "Seizures associated with antidepressants: a review." J Clin Psychiatry 54 (1993): 289-99. [PMID: 8253696]
45 Pisani F, Spina E, Oteri G "Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice." Epilepsia 40(Suppl 10) (1999): S48-56. [PMID: 10609604]
46 Product Information. Aplenzin (buPROPion). sanofi-aventis , Bridgewater, NJ.
47 Park-Wyllie LY, Juurlink DN, Kopp A, et al. "Outpatient gatifloxacin therapy and dysglycemia in older adults." N Engl J Med 354 (2006): 1352-61. [PMID: 16510739]
48 Saraya A, Yokokura M, Gonoi T, Seino S "Effects of fluoroquinolones on insulin secretion and beta-cell ATP-sensitive K(+) channels." Eur J Pharmacol 497 (2004): 111-7. [PMID: 15321742]
49 Product Information. Cymbalta (duloxetine). Lilly, Eli and Company, Indianapolis, IN.
50 Uwe F, Strobl G, Manaut F, et al "Quinolone antibacterial agents: relationship between structure and in vitro inhibition of the human cytochrome P450 isofaorm CYP1A2." Mol Pharmacol 43 (1993): 191-9. [PMID: 8429824]
51 Product Information. Isovue-M-200 (iopamidol). Bracco Diagnostics Inc, Princeton, NJ.
52 Product Information. Amipaque (metrizamide) Nycomed Inc, Princeton, NJ.
53 Hindmarsh T, Grepe A, Widen L "Metrizamide-phenothiazine interaction: report of a case with seizures following myelography." Acta Radiol Diagn (Stockh) 16 (1975): 129-35. [PMID: 810000]
54 Product Information. Omnipaque 180 (iohexol). Amersham Health, Princeton, NJ.
55 Product Information. Osmovist 240 (iotrolan). Berlex Canada Inc, Lachine, QC.
56 Cerner Multum, Inc. "UK Summary of Product Characteristics.".
57 Product Information. Esbriet (pirfenidone). Intermune Inc, Brisbane, CA.
58 Cerner Multum, Inc. "Australian Product Information.".
59 Product Information. Azilect (rasagiline). Teva Pharmaceuticals USA, North Wales, PA.
60 Product Information. Hetlioz (tasimelteon). Vanda Pharmaceuticals Inc, Rockville, MD.
61 Granfors MT, Backman JT, Laitila J, Neuvonen PJ "Tizanidine is mainly metabolized by cytochrome P450 1A2 in vitro." Br J Clin Pharmacol 57 (2004): 349-53. [PMID: 14998432]
62 Granfors MT, Backman JT, Neuvonen M, Ahonen J, Neuvonen PJ "Fluvoxamine drastically increases concentrations and effects of tizanidine: A potentially hazardous interaction." Clin Pharmacol Ther 75 (2004): 331-41. [PMID: 15060511]
63 Granfors MT, Backman JT, Neuvonen M, Neuvonen PJ "Ciprofloxacin greatly increases concentrations and hypotensive effect of tizanidine by inhibiting its cytochrome P450 1A2-mediated presystemic metabolism." Clin Pharmacol Ther 76 (2004): 598-606. [PMID: 15592331]
64 Momo K, Doki K, Hosono H, Homma M, Kohda Y "Drug interaction of tizanidine and fluvoxamine." Clin Pharmacol Ther 76 (2004): 509-10. [PMID: 15536467]
65 Momo K, Homma M, Kohda Y, Ohkoshi N, Yoshizawa T, Tamaoka A "Drug interaction of tizanidine and ciprofloxacin: Case report." Clin Pharmacol Ther 80 (2006): 717-9. [PMID: 17178273]
66 Product Information. Vioxx (rofecoxib). Merck & Co, Inc, West Point, PA.
67 Product Information. Zanaflex (tizanidine). Acorda Therapeutics, Hawthorne, NY.
68 Product Information. Zelboraf (vemurafenib). Genentech, South San Francisco, CA.
69 UK government "Typhoid.".
70 American Medical Association, Division of Drugs and Toxicology "Drug evaluations annual 1994." Chicago, IL: American Medical Association (1994).
71 Product Information. Vaxchora (cholera vaccine, live). PaxVax, Miami, FL.
72 Arnold LM, Nissen LR, Ng TM "Moxifloxacin and warfarin: additional evidence for a clinically relevant interaction." Pharmacotherapy 25 (2005): 904-7.[PMID: 15927911]
73 Glasheen JJ, Fugit RV, Prochazka AV "Effect of levofloxacin coadministration on the international normalized ratios during warfarin therapy--a comment." Pharmacotherapy 23 (2003): 1079-80 discussion 1080.[PMID: 12921255]
74 Bianco TM, Bussey HI, Farnett LE, Linn WD, Roush MK, Wong YW "Potential warfarin-ciprofloxacin interaction in patients receiving long-term anticoagulation." Pharmacotherapy 12 (1992): 435-9.[PMID: 1492006]
75 Product Information. Ultram (tramadol). McNeil Pharmaceutical, Raritan, NJ.
76 Gardiner JS, Blough D, Drinkard CR, et al. "Tramadol and seizures: a surveillance study in a managed care population." Pharmacotherapy 20 (2000): 1423-31. [PMID: 11130214]
77 Gavin JR 3rd, Kubin R, Choudhri S, et al "Moxifloxacin and glucose homeostasis: a pooled-analysis of the evidence from clinical and postmarketing studies." Drug Saf 27 (2004): 671-86. [PMID: 15230648]
78 Kelesidis T, Canseco E "Quinolone-induced hypoglycemia: a life-threatening but potentially reversible side effect." Am J Med 123 (2010): e5-6. [PMID: 20103009]
79 Yip C, Lee AJ "Gatifloxacin-induced hyperglycemia: a case report and summary of the current literature." Clin Ther 28 (2006): 1857-66. [PMID: 17213006]
80 Product Information. Agrylin (anagrelide). Roberts Pharmaceutical Corporation, Eatontown, NJ.
81 Carbo ML, Segura J, De la Torre R, et al "Effect of quinolones on caffeine disposition." Clin Pharmacol Ther 45 (1989): 234-40. [PMID: 2920498]
82 Carrillo JA, Benitez J "Clinically significant pharmacokinetic interactions between dietary caffeine and medications." Clin Pharmacokinet 39 (2000): 127-53. [PMID: 10976659]
83 Fuhr U, Wolff T, Harder S, Schymanski P, Staib AH "Quinolone inhibition of cytochrome P-450 dependent caffeine metabolism in human liver microsomes." Drug Metab Dispos 18 (1990): 1005-10. [PMID: 1981505]
84 Harder S, Fuhr U, Staib AH, Wolf T "Ciprofloxacin-caffeine: a drug interaction established using in vivo and in vitro investigations." Am J Med 87 (1989): 89-91. [PMID: 2589393]
85 Harder S, Staib AH, Beer C, Papenburg A, Stille W, Shah PM "4-Quinolones inhibit biotransformation of caffeine." Eur J Clin Pharmacol 35 (1988): 651-6. [PMID: 2853056]
86 Healy DP, Polk RE, Kanawati L, Rock DT, Mooney ML "Interaction between oral ciprofloxacin and caffeine in normal volunteers." Antimicrob Agents Chemother 33 (1989): 474-8. [PMID: 2729942]
87 Healy DP, Schoenle JR, Stotka J, Polk RE "Lack of interaction between lomefloxacin and caffeine in normal volunteers." Antimicrob Agents Chemother 35 (1991): 660-4. [PMID: 2069371]
88 Mahr G, Sorgel F, Granneman GR, et al "Effects of temafloxacin and ciprofloxacin on the pharmacokinetics of caffeine." Clin Pharmacokinet 22 (1992): 90-7. [PMID: 1319876]
89 Nicolau DP, Nightingale CH, Tessier PR, et al. "The effect of fleroxacin and ciprofloxacin on the pharmacokinetics of multiple dose caffeine." Drugs 49 Suppl 2 (1995): 357-9. [PMID: 8549360]
90 Polk RE "Drug-drug interactions with ciprofloxacin and other fluoroquinolones." Am J Med 87 (1989): s76-81. [PMID: 2686430]
91 Product Information. Noroxin (norfloxacin). Merck & Co, Inc, West Point, PA.
92 Product Information. Penetrax (enoxacin). Rhone-Poulenc Rorer, Collegeville, PA. (1993):.
93 Product Information. Raxar (grepafloxacin). Glaxo Wellcome, Research Triangle Park, NC.
94 Staib AH, Stille W, Dietlein G, et al. "Interaction between quinolones and caffeine." Drugs 34 Suppl 1 (1987): 170-4. [PMID: 3481318]
95 Stille W, Harder S, Micke S, et al. "Decrease of caffeine elimination in man during co-administration of 4-quinolones." J Antimicrob Chemother 20 (1987): 729-34. [PMID: 3480885]
96 Akerele JO, Okhamafe AO "Influence of oral co-administered metallic drugs on ofloxacin pharmacokinetics." J Antimicrob Chemother 28 (1991): 87-94. [PMID: 1663108]
97 Allen A, Vousden M, Porter A, Lewis A "Effect of Maalox((R)) on the bioavailability of oral gemifloxacin in healthy volunteers." Chemotherapy 45 (1999): 504-11. [PMID: 10567782]
98 Campbell NR, Kara M, Hasinoff BB, Haddara WM, McKay DW "Norfloxacin interaction with antacids and minerals." Br J Clin Pharmacol 33 (1992): 115-6. [PMID: 1540482]
99 Frost RW, Lasseter KC, Noe AJ, Shamblen EC, Lettieri JT "Effects of aluminum hydroxide and calcium carbonate antacids on the bioavailability of ciprofloxacin." Antimicrob Agents Chemother 36 (1992): 830-2. [PMID: 1503446]
100 Garrelts JC, Godley PJ, Peterie JD, Gerlach EH, Yakshe CC "Sucralfate significantly reduces ciprofloxacin concentrations in serum." Antimicrob Agents Chemother 34 (1990): 931-3. [PMID: 2360833]
101 Grasela TH Jr, Schentag JJ, Sedman AJ, et al "Inhibition of enoxacin absorption by antacids or ranitidine." Antimicrob Agents Chemother 33 (1989): 615-7. [PMID: 2751276]
102 Honig PK, Gillespie BK "Clinical significance of pharmacokinetic drug interactions with over-the-counter (OTC) drugs." Clin Pharmacokinet 35 (1998): 167-71. [PMID: 9784931]
103 Johnson RD, Dorr MB, Talbot GH, Caille G "Effect of Maalox on the oral absorption of sparfloxacin." Clin Ther 20 (1998): 1149-58. [PMID: 9916608]
104 Kamberi M, Nakashima H, Ogawa K, Oda N, Nakano S "The effect of staggered dosing of sucralfate on oral bioavailability of sparfloxacin." Br J Clin Pharmacol 49 (2000): 98-103. [PMID: 10671902]
105 Lehto P, Kivisto KT "Different effects of products containing metal ions on the absorption of lomefloxacin." Clin Pharmacol Ther 56 (1994): 477-82. [PMID: 7955811]
106 Lehto P, Kivisto KT "Effect of sucralfate on absorption of norfloxacin and ofloxacin." Antimicrob Agents Chemother 38 (1994): 248-51. [PMID: 8192452]
107 Lober S, Ziege S, Rau M, Schreiber G, Mignot A, Koeppe P, Lode H "Pharmacokinetics of gatifloxacin and interaction with an antacid containing aluminum and magnesium." Antimicrob Agents Chemother 43 (1999): 1067-71. [PMID: 10223915]
108 Nix DE, Watson WA, Lener ME, et al "Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin." Clin Pharmacol Ther 46 (1989): 700-5. [PMID: 2598571]
109 Nix DE, Wilton JH, Ronald B, Distlerath L, Williams VC, Norman A "Inhibition of norfloxacin absorption by antacids." Antimicrob Agents Chemother 34 (1990): 432-5. [PMID: 2334155]
110 Noyes M, Polk RE "Norfloxacin and absorption of magnesium-aluminum." Ann Intern Med 109 (1988): 168-9. [PMID: 3382110]
111 Parpia SH, Nix DE, Hejmanowski LG, Goldstein HR, Wilton JH, Schentag JJ "Sucralfate reduces the gastrointestinal absorption of norfloxacin." Antimicrob Agents Chemother 33 (1989): 99-102. [PMID: 2712548]
112 Polk RE, Helay DP, Sahai J, Drwal L, Racht E "Effect of ferrous sulfate and multivitamins with zinc on absorption of ciprofloxacin in normal volunteers." Antimicrob Agents Chemother 33 (1989): 1841-4. [PMID: 2610494]
113 Product Information. Factive (gemifloxacin). GeneSoft Inc, San Francisco, CA.
114 Product Information. Suprep Bowel Prep Kit (magnesium/potassium/sodium sulfates). Braintree Laboratories, Braintree, MA.
115 Product Information. Trovan (trovafloxacin). Pfizer US Pharmaceuticals, New York, NY.
116 Product Information. Zagam (sparfloxacin). Rhone-Poulenc Rorer, Collegeville, PA.
117 Sahai J, Healy DP, Stotka J, Polk RE "The influence of chronic administration of calcium carbonate on the bioavailability of oral ciprofloxacin." Br J Clin Pharmacol 35 (1993): 302-4. [PMID: 8471407]
118 Shimada J, Shiba K, Oguma T, et al "Effect of antacid on absorption of the quinolone lomefloxacin." Antimicrob Agents Chemother 36 (1992): 1219-24. [PMID: 1329615]
119 Spivey JM, Cummings DM, Pierson NR "Failure of prostatitis treatment secondary to probable ciprofloxacin-sucralfate drug interaction." Pharmacotherapy 16 (1996): 314-6. [PMID: 8820479]
120 Teng R, Dogolo LC, Willavize SA, Friedman HL, Vincent J "Effect of Maalox and omeprazole on the bioavailability of trovafloxacin." J Antimicrob Chemother 39 Suppl B (1997): 93-7. [PMID: 9222077]
121 Wadworth AN, Goa KL "Lomefloxacin: a review of its antibacterial activity, pharmacokinetic properties and therapeutic use." Drugs 42 (1991): 1018-60. [PMID: 1724637]
122 Yuk JH "Ciprofloxacin levels when receiving sucralfate." J Am Geriatr Soc 262 (1989): 901. [PMID: 2754785]
123 Zix JA, Geerdes-Fenge HF, Rau M, Vockler J, Borner K, Koeppe P, Lode H "Pharmacokinetics of sparfloxacin and interaction with cisapride and sucralfate." Antimicrob Agents Chemother 41 (1997): 1668-72. [PMID: 9257738]
124 Deppermann KM, Lode H, Hoffken G, Tschink G, Kalz C, Koeppe P "Influence of ranitidine, pirenzepine, and aluminum magnesium hydroxide on the bioavailability of various antibiotics, including amoxicillin, cephalexin, doxycycline, and amoxicillin-clavulanic acid." Antimicrob Agents Chemother 33 (1989): 1901-7. [PMID: 2610502]
125 Agencia Espaola de Medicamentos y Productos Sanitarios Healthcare "Centro de informacion online de medicamentos de la AEMPS - CIMA.".
126 Cerner Multum, Inc "ANVISA Bulario Eletrnico.".
127 Lemma GL, Desta Z, Jones DR, Gorski JC, Hall SD "Droperidol is predominantly metabolized by human CYP3A enzymes." Clin Pharmacol Ther 73 (2003): 16.
128 Product Information. Droperidol (droperidol). Abbott Pharmaceutical, Abbott Park, IL.
129 Product Information. Inapsine (droperidol). Janssen Pharmaceutica, Titusville, NJ.
130 Davey PG "Overview of drug interactions with the quinolones." J Antimicrob Chemother 22(suppl c) (1988): 97-107. [PMID: 3053579]
131 Product Information. Lotronex (alosetron). Glaxo Wellcome, Research Triangle Park, NC.
132 EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
133 Product Information. Firdapse (amifampridine). Catalyst Pharmaceuticals, Inc., Coral Gables, FL.
134 Product Information. Metvixia (methyl aminolevulinate topical). Galderma Laboratories Inc, Cranbury, NJ.
135 Product Information. Saphris (asenapine). Schering-Plough Corporation, Kenilworth, NJ.
136 Product Information. Colazal (balsalazide) Salix Pharmaceuticals, Palo Alto, CA.
137 Product Information. Treanda (bendamustine). Cephalon Inc, West Chester, PA.
138 Product Information. Floxin (ofloxacin). Ortho Pharmaceutical Corporation, Raritan, NJ.
139 Product Information. Penetrex (enoxacin). Rhone-Poulenc Rorer, Collegeville, PA.
140 Product Information. Tequin (gatifloxacin) Bristol-Myers Squibb, Princeton, NJ.
141 Ball P, Tillotson G "Tolerability of fluoroquinolone antibiotics: past, present and future." Drug Saf 13 (1996): 343-8. [PMID: 8652079]
142 Segev S. Rehavi M, Rubinstein E "Quinolones, theophylline, and diclofenac interactions with the gamma-aminobutyric acid receptor." Antimicrob Agents Chemother 32 (1988): 1624-6. [PMID: 2855295]
143 Domagala JM "Structure-activity and structure-side-effect relationships for the quinolone antibacterials." J Antimicrob Chemother 33 (1994): 685-706. [PMID: 8056688]
144 Hooper DC, Wolfson JS "The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans." Antimicrob Agents Chemother 28 (1985): 716-21. [PMID: 2936302]
145 Ball P "Ciprofloxacin: an overview of adverse experiences." J Antimicrob Chemother 18 (1986): 187-93. [PMID: 3542945]
146 Wojcikowski J, Boksa J, Daniel WA "Main contribution of the cytochrome P450 isoenzyme 1A2 (CYP1A2) to N-demethylation and 5-sulfoxidation of the phenothiazine neuroleptic chlorpromazine in human liver--A comparison with other phenothiazines." Biochem Pharmacol 80 (2010): 1252-9. [PMID: 20615392]
147 Multum Information Services, Inc. Expert Review Panel.
148 Deppermann KM, Lode H "Fluoroquinolones: interaction profile during enteral absorption." Drugs 45 Suppl 3 (1993): 65-72. [PMID: 7689454]
149 Knupp CA, Barbhaiya RH "A multiple-dose pharmacokinetic interaction study between didanosine (videx(r)) and ciprofloxacin (cipro(r)) in male subjects seropositive for HIV but asymptomatic." Biopharm Drug Dispos 18 (1997): 65-77. [PMID: 9008270]
150 Marchbanks CR "Drug-drug interactions with fluoroquinolones." Pharmacotherapy 13 (1993): s23-8. [PMID: 8474934]
151 Mizuki Y, Fujiwara I, Yamaguchi T "Pharmacokinetic interactions related to the chemical structures of fluoroquinolones." J Antimicrob Chemother 37 Suppl A (1996): 41-55. [PMID: 8737124]
152 Product Information. Videx (didanosine). Bristol-Myers Squibb, Princeton, NJ.
153 Sahai J, Gallicano K, Oliveras L, Khaliq S, Hawley-Foss N, Garber G "Cations in the didanosine tablet reduce ciprofloxacin bioavailability." Clin Pharmacol Ther 53 (1993): 292-7. [PMID: 8453847]
154 Shiba K, Sakamoto M, Nakazawa Y, Sakai O "Effects of antacid on absorption and excretion of new quinolones." Drugs 49(Suppl 2) (1995): 360-1. [PMID: 8549362]
155 Damle BD, Mummaneni V, Kaul S, Knupp C "Lack of Effect of Simultaneously Administered Didanosine Encapsulated Enteric Bead Formulation (Videx EC) on Oral Absorption of Indinavir, Ketoconazole, or Ciprofloxacin." Antimicrob Agents Chemother 46 (2002): 385-91. [PMID: 11796346]
156 Product Information. Viberzi (eluxadoline). Actavis Pharma, Inc., Parsippany, NJ.
157 Friedman CI, Huneke AL, Kim MH, Powell J "The effect of ampicillin on oral contraceptive effectiveness." Obstet Gynecol 55 (1980): 33-7. [PMID: 7188714]
158 Kleier DJ, Tucker JE "Oral contraceptive failure secondary to dentally prescribed drugs: fact or fiction?" J Colo Dent Assoc 66 (1987): 5-6. [PMID: 3478352]
159 Silber TJ "Apparent oral contraceptive failure associated with antibiotic administration." J Adolesc Health Care 4 (1983): 287-9. [PMID: 6643209]
160 Kajiyama Y, Fujii K, Takeuchi H, Manabe Y "Ginkgo seed poisoning." Pediatrics 109 (2002): 325-7. [PMID: 11826216]
161 Granger AS "Ginkgo biloba precipitating epileptic seizures." Age Ageing 30 (2001): 523-5. [PMID: 11742783]
162 Miller LG "Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions." Arch Intern Med 158 (1998): 2200-11. [PMID: 9818800]
163 Spinella M "Herbal medicines and epilepsy: the potential for benefit and adverse effects." Epilepsy Behav 2 (2001): 524-32. [PMID: 12609386]
164 Gregory PJ "Seizure associated with Ginkgo biloba?." Ann Intern Med 134 (2001): 344. [PMID: 11182853]
165 Harms SL, Garrard J, Schwinghammer P, Eberly LE, Chang Y, Leppik IE "Ginkgo biloba use in nursing home elderly with epilepsy or seizure disorder." Epilepsia 47 (2006): 323-9. [PMID: 16499756]
166 Miwa H, Iijima M, Tanaka S, Mizuno Y "Generalized convulsions after consuming a large amount of Gingko nuts." Epilepsia 42 (2001): 280-1. [PMID: 11240603]
167 Kupiec T, Raj V "Fatal seizures due to potential herb-drug interactions with Ginkgo biloba." J Anal Toxicol 29 (2005): 755-8. [PMID: 16419414]
168 Product Information. Indium Oxyquinoline In-111 (indium oxyquinoline In-111). GE Healthcare, Princeton, NJ.
169 Product Information. Fosrenol (lanthanum carbonate). Shire US Inc, Florence, KY.
170 Product Information. Nuzyra (omadacycline). Paratek Pharmaceuticals, Inc., Boston, MA.
171 Product Information. Seysara (sarecycline). Allergan Inc, Irvine, CA.
172 Johnson EJ, MacGowan AP, Potter MN, et al "Reduced absorption of oral ciprofloxacin after chemotherapy for haematological malignancy." J Antimicrob Chemother 25 (1990): 837-42. [PMID: 2373666]
173 Nesher G, Mates M, Zevin S "Effect of caffeine consumption on efficacy of methotrexate in rheumatoid arthritis." Arthritis Rheum 48 (2003): 571-572. [PMID: 12571869]
174 Dalle JH, Auvrignon A, Vassal G, Leverger G "Interaction Between Methotrexate and Ciprofloxacin." J Pediatr Hematol Oncol 24 (2002): 321-322
175 Product Information. Nulibry (fosdenopterin). Origin Biosciences Inc, Boston, MA.
176 Product Information. Oxsoralen (methoxsalen). ICN Pharmaceuticals Inc, Costa Mesa, CA.
177 Product Information. Uvadex (methoxsalen). Therakos Inc, Exton, PA.
178 Product Information. CellCept (mycophenolate mofetil). Roche Laboratories, Nutley, NJ.
179 Product Information. Myfortic (mycophenolic acid). Novartis Pharmaceuticals, East Hanover, NJ.
180 Product Information. Alimta (pemetrexed). Lilly, Eli and Company, Indianapolis, IN.
181 Magnusson M, Bergstrand IC, Bjorkman S, Heijl A, Roth B, Hoglund P "A placebo-controlled study of retinal blood flow changes by pentoxifylline and metabolites in humans." Br J Clin Pharmacol 61 (2006): 138-47. [PMID: 16433868]
182 Product Information. Trental (pentoxifylline). Hoechst Marion-Roussel Inc, Kansas City, MO.
183 Krahenbuhl S, Sauter B, Kupferschmidt H, Krause M, Wyss PA, Meier PJ "Case report: reversible QT prolongation with torsades de pointes in a patient with pimozide intoxication." Am J Med Sci 309 (1995): 315-6. [PMID: 7771501]
184 Product Information. Orap Tablets (pimozide). Gate Pharmaceuticals, Sellersville, PA.
185 Salik JM, Kurtin P "Severe hyponatremia after colonoscopy preparation in a patient with the acquired immune deficiency syndrome." Am J Gastroenterol 80 (1985): 177-9. [PMID: 2983533]
186 Product Information. Rozerem (ramelteon). Takeda Pharmaceuticals America, Lincolnshire, IL.
187 Product Information. Daliresp (roflumilast). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
188 Product Information. Daxas (roflumilast). Nycomed Inc, Princeton, NJ.
189 Kays MB, Overholser BR, Mueller BA, Moe SM, Sowinski KM "Effects of sevelamer hydrochloride and calcium acetate on the oral bioavailability of ciprofloxacin." Am J Kidney Dis 42 (2003): 1253-9. [PMID: 14655198]
190 EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
191 Product Information. Diacomit (stiripentol). Biocodex Inc, Creswell, OR.
192 Product Information. Baraclude (entecavir). Bristol-Myers Squibb, Princeton, NJ.
193 Matsuoka LY "Convulsions following application of gamma benzene hexachloride." J Am Acad Dermatol 5 (1981): 98-9. [PMID: 6168673]
194 Cox R, Krupnick J, Bush N, Houpt A "Seizures caused by concomitant use of lindane and dextroamphetamine in a child with attention deficit hyperactivity disorder." J Miss State Med Assoc 41 (2000): 690-2. [PMID: 10974795]
195 Product Information. Kwell (lindane). Reed and Carnrick, Jersey City, NJ.
196 Okubo M, Murayama N, Miura J, Chiba Y, Yamazaki H "Effects of cytochrome P450 2D6 and 3A5 genotypes and possible coadministered medicines on the metabolic clearance of antidepressant mirtazapine in Japanese patients." Biochem Pharmacol 93 (2015): 104-9. [PMID: 25475885]
197 Product Information. Remeron (mirtazapine). Organon, West Orange, NJ.
198 Product Information. Varubi (rolapitant). Tesaro Inc., Waltham, MA.
199 Sitsen JM, Maris FA, Timmer CJ "Concomitant use of mirtazapine and cimetidine: a drug-drug interaction study in healthy male subjects." Eur J Clin Pharmacol 56 (2000): 389-94. [PMID: 11009047]
200 Stormer E, von Moltke LL, Shader RI, Greenblatt DJ "Metabolism of the antidepressant mirtazapine in vitro: contribution of cytochromes P-450 1A2, 2D6, and 3A4" Drug Metab Dispos 28 (2000): 1168-75. [PMID: 10997935]
201 Product Information. Requip (ropinirole). SmithKline Beecham, Philadelphia, PA.
202 Product Information. Visudyne (verteporfin) Valeant Pharmaceuticals, Costa Mesa, CA.
203 Sudoh T, Fujimura A, Shiga T, Sasaki M, Harada K, Tateishi T, Ohashi K, Ebihara A "Renal clearance of lomefloxacin is decreased by furosemide." Eur J Clin Pharmacol 46 (1994): 267-9. [PMID: 8070509]
204 Lebsack ME, Nix D, Ryerson B, et al "Effect of gastric acidity on enoxacin absorption." Clin Pharmacol Ther 52 (1992): 252-6. [PMID: 1526081]
205 Misiak PM, Eldon MA, Toothaker RD, Sedman AJ "Effects of oral cimetidine or ranitidine on the pharmacokinetics of intravenous enoxacin." J Clin Pharmacol 33 (1993): 53-6. [PMID: 8429114]
206 Weidekamm E, Portmann R, Suter K, et al "Single- and multiple-dose pharmacokinetics of fleroxacin, a trifluorinated quinolone, in humans." Antimicrob Agents Chemother 31 (1987): 1909-14
207 Shimada J, Yamaji T, Ueda Y, Uchida H, Kusajma H, Irikura T "Mechanism of renal excretion of AM-715, a new quinolonecarboxylic acid derivative, in rabbits, dogs, and humans." Antimicrob Agents Chemother 23 (1983): 1-7
208 Product Information. Rilutek (riluzole). Rhone-Poulenc Rorer, Collegeville, PA.
209 Granfors MT, Backman JT, Neuvonen M, Neuvonen PJ. Ciprofloxacin greatly increases concentrations and hypotensive effect of tizanidine by inhibiting its cytochrome P450 1A2-mediated presystemic metabolism.?Clin Pharmacol Ther. 2004;76(6):598-606. [PMID: 15592331]
210 McLellan RA, Drobitch RK, Monshouwer M, Renton KW "Fluoroquinolone antibiotics inhibit cytochrome P450-mediated microsomal drug metabolism in rat and human." Drug Metab Dispos 24 (1996): 1134-8. [PMID: 8894516]
211 Albers LJ, Ozdemir V, Marder SR, et al. "Low-dose fluvoxamine as an adjunct to reduce olanzapine therapeutic dose requirements: a prospective dose-adjusted drug interaction strategy." J Clin Psychopharmacol 25 (2005): 170-174. [PMID: 15738749]
212 Bergemann N, Frick A, Parzer P, Kopitz J "Olanzapine plasma concentration, average daily dose, and interaction with co-medication in schizophrenic patients." Pharmacopsychiatry 37 (2004): 63-8. [PMID: 15048613]
213 Brosen K, Skjelbo E, Rasmussen BB, Poulsen HE, Loft S "Fluvoxamine is a potent inhibitor of cytochrome P4501A2." Biochem Pharmacol 45 (1993): 1211-4. [PMID: 8466541]
214 Callaghan JT, Bergstrom RF, Ptak LR, Beasley CM "Olanzapine. Pharmacokinetic and pharmacodynamic profile." Clin Pharmacokinet 37 (1999): 177-93. [PMID: 10511917]
215 Chiu CC, Lane HY, Huang MC, et al. "Dose-dependent alternations in the pharmacokinetics of olanzapine during coadministration of fluvoxamine in patients with schizophrenia." J Clin Pharmacol 44 (2004): 1385-90. [PMID: 15545309]
216 de Jong J, Hoogenboom B, van Troostwijk LD, de Haan L "Interaction of olanzapine with fluvoxamine." Psychopharmacology (Berl) 155 (2001): 219-20. [PMID: 11401013]
217 Desai HD, Seabolt J, Jann MW "Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective." CNS Drugs 15 (2001): 469-94. [PMID: 11524025]
218 Gex-Fabry M, Balant-Gorgia AE, Balant LP "Therapeutic drug monitoring of olanzapine: the combined effect of age, gender, smoking, and comedication." Ther Drug Monit 25 (2003): 46-53. [PMID: 12548144]
219 Gossen D, de Suray JM, Vandenhende F, Onkelinx C, Gangji D "Influence of fluoxetine on olanzapine pharmacokinetics." AAPS PharmSci 4 (2002): E11. [PMID: 12102620]
220 Hiemke C, Peled A, Jabarin M, et al. "Fluvoxamine augmentation of olanzapine in chronic schizophrenia: pharmacokinetic interactions and clinical effects." J Clin Psychopharmacol 22 (2002): 502-6. [PMID: 12352274]
221 Letsas KP, Sideris A, Kounas SP, Efremidis M, Korantzopoulos P, Kardaras F "Drug-induced QT interval prolongation after ciprofloxacin administration in a patient receiving olanzapine." Int J Cardiol 109 (2006): 273-4. [PMID: 15935493]
222 Markowitz JS, DeVane CL "Suspected ciprofloxacin inhibition of olanzapine resulting in increased plasma concentration." J Clin Psychopharmacol 19 (1999): 289-91. [PMID: 10350045]
223 Product Information. Lybalvi (olanzapine-samidorphan). Alkermes, Inc, Cambridge, MA.
224 Product Information. Qelbree (viloxazine). Supernus Pharmaceuticals Inc, Rockville, MD.
225 Product Information. Zyprexa (olanzapine). Lilly, Eli and Company, Indianapolis, IN.
226 Wang CY, Zhang ZJ, Li WB, et al. "The differential effects of steady-state fluvoxamine on the pharmacokinetics of olanzapine and clozapine in healthy volunteers." J Clin Pharmacol 44 (2004): 785-92. [PMID: 15199083]
227 Weigmann H, Gerek S, Zeisig A, Muller M, Hartter S, Hiemke C "Fluvoxamine but not sertraline inhibits the metabolism of olanzapine: evidence from a therapeutic drug monitoring service." Ther Drug Monit 23 (2001): 410-3. [PMID: 11477325]